babesiosis

babesiosis
Name	Babesiosis
Caption	Babesia microti trophozoites in a blood smear
Field	Infectious disease
Symptoms	Fever, chills, sweats, fatigue, hemolytic anemia
Complications	Severe hemolysis, acute respiratory distress syndrome, renal failure
Causes	Infection by Babesia parasites
Risks	Splenectomy, immunosuppression, exposure in endemic areas
Diagnosis	Microscopy of blood smear, PCR, serology
Treatment	Atovaquone plus azithromycin; clindamycin plus quinine
Prevention	Tick bite prevention, screening of blood donations

babesiosis. Babesiosis is a malaria-like tick-borne disease caused by infection with protozoan parasites of the genus Babesia. The illness, first described by Victor Babeș in Romania, ranges from asymptomatic to severe, with the primary vectors being Ixodes scapularis and Ixodes pacificus ticks in the United States. Most human cases in North America are caused by Babesia microti, while in Europe Babesia divergens is more common, and the disease is recognized as an emerging zoonosis with significant public health implications.

Overview

The disease is named for Victor Babeș, who in 1888 identified the causative organisms in cattle in Romania. The first confirmed human case was reported in 1957 in a splenectomized individual in Yugoslavia. Babesiosis shares clinical features with malaria, as both involve intraerythrocytic parasites causing hemolytic anemia, but they are transmitted by different vectors and caused by distinct apicomplexan parasites. The World Health Organization classifies it as a neglected tropical disease in some regions, and its incidence has been increasing in endemic areas like the Northeastern United States and the Upper Midwest.

Causes and transmission

Human babesiosis is primarily caused by several species of the apicomplexan genus Babesia. In the United States, Babesia microti is the predominant agent, transmitted by the black-legged tick, Ixodes scapularis, which also vectors Lyme disease and anaplasmosis. In Europe, most cases are attributed to Babesia divergens, associated with the Ixodes ricinus tick. Transmission occurs through the bite of an infected tick during its nymphal or adult stage. Other routes include transfusion-transmitted infection via contaminated blood products and, rarely, congenital transmission. The primary reservoir hosts are small rodents, such as the white-footed mouse for B. microti.

Signs and symptoms

The clinical presentation varies widely. Many infections, particularly in healthy individuals, are asymptomatic. Symptomatic disease often begins with nonspecific, influenza-like symptoms including fever, chills, drenching sweats, myalgia, arthralgia, and fatigue. Physical examination may reveal hepatomegaly or splenomegaly. A hallmark of severe infection is hemolytic anemia, which can lead to hemoglobinuria and jaundice. Severe complications, more common in asplenic, elderly, or immunocompromised patients, can include acute respiratory distress syndrome, congestive heart failure, renal failure, and disseminated intravascular coagulation. The case fatality rate for recognized infections is estimated at around 5-9% in high-risk groups.

Diagnosis

Diagnosis relies on a high index of suspicion, especially in patients from endemic areas with unexplained fever and hemolytic anemia. Laboratory confirmation is typically achieved by identifying the parasite on Giemsa-stained blood smears, where intraerythrocytic ring forms resembling those of malaria may be seen, sometimes in a characteristic "Maltese cross" tetrad formation. Serology, particularly the indirect fluorescent antibody test for B. microti, is useful for detecting antibodies. More sensitive molecular techniques like polymerase chain reaction can detect Babesia DNA in blood and are increasingly used. Other supportive lab findings include thrombocytopenia, elevated liver function tests, and elevated creatinine.

Treatment and prevention

For mild to moderate illness, the standard regimen is a combination of atovaquone and azithromycin for 7-10 days. For severe disease (e.g., high-grade parasitemia, significant hemolysis, or organ failure), the recommended treatment is intravenous clindamycin and oral quinine; exchange transfusion may be considered in life-threatening cases. Doxycycline, effective for other tick-borne illnesses, is not active against Babesia. Prevention focuses on avoiding tick bites through the use of DEET repellents, permethrin-treated clothing, and tick checks. In endemic regions, the American Red Cross and Food and Drug Administration recommend screening blood donations for Babesia to prevent transfusion-associated cases. No vaccine is currently available for humans.

Epidemiology

Babesiosis is endemic in specific geographic regions. In the United States, the majority of cases are reported from the Northeastern United States (e.g., Massachusetts, New York, Connecticut) and the Upper Midwest (Wisconsin, Minnesota). Surveillance data from the Centers for Disease Control and Prevention show a marked increase in reported cases since the 1990s. In Europe, sporadic cases occur, notably in France, the British Isles, and the Balkan Peninsula, often linked to B. divergens. The expanding range of Ixodes scapularis, influenced by factors like climate change and reforestation, is contributing to the disease's emergence in new areas such as Canada. Occupational risk is higher for individuals like forestry workers and farmers.

Category:Tick-borne diseases Category:Protozoal diseases Category:Zoonoses